PF-06952229

PF-06952229 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06952229, covering 2024-06-26 to 2024-06-26. Get the full timeline:

Most recent: Clinical Trial Update: PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors [Phase 1]